Global GIP-1 Receptor Agonist Supply, Demand and Key Producers, 2023-2029

July 2024 | 112 pages | ID: G4D170979684EN
GlobalInfoResearch

Abstracts

The global GIP-1 Receptor Agonist market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

GIP-1 receptor agonists are a class of drugs for the treatment of type 2 diabetes. This type of drug can exert the effect of incretin by stimulating the glucagon-like peptide-1 receptor to produce a hypoglycemic effect. showed advantages in protection.

This report studies the global GIP-1 Receptor Agonist production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for GIP-1 Receptor Agonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GIP-1 Receptor Agonist that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global GIP-1 Receptor Agonist total production and demand, 2018-2029, (K Units)

Global GIP-1 Receptor Agonist total production value, 2018-2029, (USD Million)

Global GIP-1 Receptor Agonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GIP-1 Receptor Agonist consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: GIP-1 Receptor Agonist domestic production, consumption, key domestic manufacturers and share

Global GIP-1 Receptor Agonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global GIP-1 Receptor Agonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GIP-1 Receptor Agonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global GIP-1 Receptor Agonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Novo Nordisk, Eli Lilly and Company, Baxter Pharmaceutical Solutions, Sanofi, AstraZeneca, Shanghai Benemae Pharmaceutical Corporation, Sinopep Allsino Bio Pharmaceutical and Huadong Medicine, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GIP-1 Receptor Agonist market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global GIP-1 Receptor Agonist Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global GIP-1 Receptor Agonist Market, Segmentation by Type

• Short-acting GLP-1 Receptor Agonist
• Long-acting GLP-1 Receptor Agonist

Global GIP-1 Receptor Agonist Market, Segmentation by Application

• Type 2 Diabetics
• Obese Patients
• Others

Companies Profiled:

• GSK
• Novo Nordisk
• Eli Lilly and Company
• Baxter Pharmaceutical Solutions
• Sanofi
• AstraZeneca
• Shanghai Benemae Pharmaceutical Corporation
• Sinopep Allsino Bio Pharmaceutical
• Huadong Medicine
• HANSOH PHARMA
• 3SBio

Key Questions Answered

1. How big is the global GIP-1 Receptor Agonist market?

2. What is the demand of the global GIP-1 Receptor Agonist market?

3. What is the year over year growth of the global GIP-1 Receptor Agonist market?

4. What is the production and production value of the global GIP-1 Receptor Agonist market?

5. Who are the key producers in the global GIP-1 Receptor Agonist market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 GIP-1 Receptor Agonist Introduction
1.2 World GIP-1 Receptor Agonist Supply & Forecast
  1.2.1 World GIP-1 Receptor Agonist Production Value (2018 & 2022 & 2029)
  1.2.2 World GIP-1 Receptor Agonist Production (2018-2029)
  1.2.3 World GIP-1 Receptor Agonist Pricing Trends (2018-2029)
1.3 World GIP-1 Receptor Agonist Production by Region (Based on Production Site)
  1.3.1 World GIP-1 Receptor Agonist Production Value by Region (2018-2029)
  1.3.2 World GIP-1 Receptor Agonist Production by Region (2018-2029)
  1.3.3 World GIP-1 Receptor Agonist Average Price by Region (2018-2029)
  1.3.4 North America GIP-1 Receptor Agonist Production (2018-2029)
  1.3.5 Europe GIP-1 Receptor Agonist Production (2018-2029)
  1.3.6 China GIP-1 Receptor Agonist Production (2018-2029)
  1.3.7 Japan GIP-1 Receptor Agonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 GIP-1 Receptor Agonist Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 GIP-1 Receptor Agonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World GIP-1 Receptor Agonist Demand (2018-2029)
2.2 World GIP-1 Receptor Agonist Consumption by Region
  2.2.1 World GIP-1 Receptor Agonist Consumption by Region (2018-2023)
  2.2.2 World GIP-1 Receptor Agonist Consumption Forecast by Region (2024-2029)
2.3 United States GIP-1 Receptor Agonist Consumption (2018-2029)
2.4 China GIP-1 Receptor Agonist Consumption (2018-2029)
2.5 Europe GIP-1 Receptor Agonist Consumption (2018-2029)
2.6 Japan GIP-1 Receptor Agonist Consumption (2018-2029)
2.7 South Korea GIP-1 Receptor Agonist Consumption (2018-2029)
2.8 ASEAN GIP-1 Receptor Agonist Consumption (2018-2029)
2.9 India GIP-1 Receptor Agonist Consumption (2018-2029)

3 WORLD GIP-1 RECEPTOR AGONIST MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World GIP-1 Receptor Agonist Production Value by Manufacturer (2018-2023)
3.2 World GIP-1 Receptor Agonist Production by Manufacturer (2018-2023)
3.3 World GIP-1 Receptor Agonist Average Price by Manufacturer (2018-2023)
3.4 GIP-1 Receptor Agonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global GIP-1 Receptor Agonist Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for GIP-1 Receptor Agonist in 2022
  3.5.3 Global Concentration Ratios (CR8) for GIP-1 Receptor Agonist in 2022
3.6 GIP-1 Receptor Agonist Market: Overall Company Footprint Analysis
  3.6.1 GIP-1 Receptor Agonist Market: Region Footprint
  3.6.2 GIP-1 Receptor Agonist Market: Company Product Type Footprint
  3.6.3 GIP-1 Receptor Agonist Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: GIP-1 Receptor Agonist Production Value Comparison
  4.1.1 United States VS China: GIP-1 Receptor Agonist Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: GIP-1 Receptor Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GIP-1 Receptor Agonist Production Comparison
  4.2.1 United States VS China: GIP-1 Receptor Agonist Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: GIP-1 Receptor Agonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GIP-1 Receptor Agonist Consumption Comparison
  4.3.1 United States VS China: GIP-1 Receptor Agonist Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: GIP-1 Receptor Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GIP-1 Receptor Agonist Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based GIP-1 Receptor Agonist Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers GIP-1 Receptor Agonist Production Value (2018-2023)
  4.4.3 United States Based Manufacturers GIP-1 Receptor Agonist Production (2018-2023)
4.5 China Based GIP-1 Receptor Agonist Manufacturers and Market Share
  4.5.1 China Based GIP-1 Receptor Agonist Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers GIP-1 Receptor Agonist Production Value (2018-2023)
  4.5.3 China Based Manufacturers GIP-1 Receptor Agonist Production (2018-2023)
4.6 Rest of World Based GIP-1 Receptor Agonist Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based GIP-1 Receptor Agonist Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers GIP-1 Receptor Agonist Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers GIP-1 Receptor Agonist Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World GIP-1 Receptor Agonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Short-acting GLP-1 Receptor Agonist
  5.2.2 Long-acting GLP-1 Receptor Agonist
5.3 Market Segment by Type
  5.3.1 World GIP-1 Receptor Agonist Production by Type (2018-2029)
  5.3.2 World GIP-1 Receptor Agonist Production Value by Type (2018-2029)
  5.3.3 World GIP-1 Receptor Agonist Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World GIP-1 Receptor Agonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Type 2 Diabetics
  6.2.2 Obese Patients
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World GIP-1 Receptor Agonist Production by Application (2018-2029)
  6.3.2 World GIP-1 Receptor Agonist Production Value by Application (2018-2029)
  6.3.3 World GIP-1 Receptor Agonist Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 GSK
  7.1.1 GSK Details
  7.1.2 GSK Major Business
  7.1.3 GSK GIP-1 Receptor Agonist Product and Services
  7.1.4 GSK GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 GSK Recent Developments/Updates
  7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Details
  7.2.2 Novo Nordisk Major Business
  7.2.3 Novo Nordisk GIP-1 Receptor Agonist Product and Services
  7.2.4 Novo Nordisk GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Novo Nordisk Recent Developments/Updates
  7.2.6 Novo Nordisk Competitive Strengths & Weaknesses
7.3 Eli Lilly and Company
  7.3.1 Eli Lilly and Company Details
  7.3.2 Eli Lilly and Company Major Business
  7.3.3 Eli Lilly and Company GIP-1 Receptor Agonist Product and Services
  7.3.4 Eli Lilly and Company GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Eli Lilly and Company Recent Developments/Updates
  7.3.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.4 Baxter Pharmaceutical Solutions
  7.4.1 Baxter Pharmaceutical Solutions Details
  7.4.2 Baxter Pharmaceutical Solutions Major Business
  7.4.3 Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Product and Services
  7.4.4 Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Baxter Pharmaceutical Solutions Recent Developments/Updates
  7.4.6 Baxter Pharmaceutical Solutions Competitive Strengths & Weaknesses
7.5 Sanofi
  7.5.1 Sanofi Details
  7.5.2 Sanofi Major Business
  7.5.3 Sanofi GIP-1 Receptor Agonist Product and Services
  7.5.4 Sanofi GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Sanofi Recent Developments/Updates
  7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 AstraZeneca
  7.6.1 AstraZeneca Details
  7.6.2 AstraZeneca Major Business
  7.6.3 AstraZeneca GIP-1 Receptor Agonist Product and Services
  7.6.4 AstraZeneca GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 AstraZeneca Recent Developments/Updates
  7.6.6 AstraZeneca Competitive Strengths & Weaknesses
7.7 Shanghai Benemae Pharmaceutical Corporation
  7.7.1 Shanghai Benemae Pharmaceutical Corporation Details
  7.7.2 Shanghai Benemae Pharmaceutical Corporation Major Business
  7.7.3 Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Product and Services
  7.7.4 Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates
  7.7.6 Shanghai Benemae Pharmaceutical Corporation Competitive Strengths & Weaknesses
7.8 Sinopep Allsino Bio Pharmaceutical
  7.8.1 Sinopep Allsino Bio Pharmaceutical Details
  7.8.2 Sinopep Allsino Bio Pharmaceutical Major Business
  7.8.3 Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Product and Services
  7.8.4 Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Sinopep Allsino Bio Pharmaceutical Recent Developments/Updates
  7.8.6 Sinopep Allsino Bio Pharmaceutical Competitive Strengths & Weaknesses
7.9 Huadong Medicine
  7.9.1 Huadong Medicine Details
  7.9.2 Huadong Medicine Major Business
  7.9.3 Huadong Medicine GIP-1 Receptor Agonist Product and Services
  7.9.4 Huadong Medicine GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Huadong Medicine Recent Developments/Updates
  7.9.6 Huadong Medicine Competitive Strengths & Weaknesses
7.10 HANSOH PHARMA
  7.10.1 HANSOH PHARMA Details
  7.10.2 HANSOH PHARMA Major Business
  7.10.3 HANSOH PHARMA GIP-1 Receptor Agonist Product and Services
  7.10.4 HANSOH PHARMA GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 HANSOH PHARMA Recent Developments/Updates
  7.10.6 HANSOH PHARMA Competitive Strengths & Weaknesses
7.11 3SBio
  7.11.1 3SBio Details
  7.11.2 3SBio Major Business
  7.11.3 3SBio GIP-1 Receptor Agonist Product and Services
  7.11.4 3SBio GIP-1 Receptor Agonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 3SBio Recent Developments/Updates
  7.11.6 3SBio Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 GIP-1 Receptor Agonist Industry Chain
8.2 GIP-1 Receptor Agonist Upstream Analysis
  8.2.1 GIP-1 Receptor Agonist Core Raw Materials
  8.2.2 Main Manufacturers of GIP-1 Receptor Agonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GIP-1 Receptor Agonist Production Mode
8.6 GIP-1 Receptor Agonist Procurement Model
8.7 GIP-1 Receptor Agonist Industry Sales Model and Sales Channels
  8.7.1 GIP-1 Receptor Agonist Sales Model
  8.7.2 GIP-1 Receptor Agonist Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World GIP-1 Receptor Agonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GIP-1 Receptor Agonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World GIP-1 Receptor Agonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World GIP-1 Receptor Agonist Production Value Market Share by Region (2018-2023)
Table 5. World GIP-1 Receptor Agonist Production Value Market Share by Region (2024-2029)
Table 6. World GIP-1 Receptor Agonist Production by Region (2018-2023) & (K Units)
Table 7. World GIP-1 Receptor Agonist Production by Region (2024-2029) & (K Units)
Table 8. World GIP-1 Receptor Agonist Production Market Share by Region (2018-2023)
Table 9. World GIP-1 Receptor Agonist Production Market Share by Region (2024-2029)
Table 10. World GIP-1 Receptor Agonist Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GIP-1 Receptor Agonist Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GIP-1 Receptor Agonist Major Market Trends
Table 13. World GIP-1 Receptor Agonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GIP-1 Receptor Agonist Consumption by Region (2018-2023) & (K Units)
Table 15. World GIP-1 Receptor Agonist Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GIP-1 Receptor Agonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GIP-1 Receptor Agonist Producers in 2022
Table 18. World GIP-1 Receptor Agonist Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GIP-1 Receptor Agonist Producers in 2022
Table 20. World GIP-1 Receptor Agonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GIP-1 Receptor Agonist Company Evaluation Quadrant
Table 22. World GIP-1 Receptor Agonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GIP-1 Receptor Agonist Production Site of Key Manufacturer
Table 24. GIP-1 Receptor Agonist Market: Company Product Type Footprint
Table 25. GIP-1 Receptor Agonist Market: Company Product Application Footprint
Table 26. GIP-1 Receptor Agonist Competitive Factors
Table 27. GIP-1 Receptor Agonist New Entrant and Capacity Expansion Plans
Table 28. GIP-1 Receptor Agonist Mergers & Acquisitions Activity
Table 29. United States VS China GIP-1 Receptor Agonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GIP-1 Receptor Agonist Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GIP-1 Receptor Agonist Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GIP-1 Receptor Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GIP-1 Receptor Agonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GIP-1 Receptor Agonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GIP-1 Receptor Agonist Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GIP-1 Receptor Agonist Production Market Share (2018-2023)
Table 37. China Based GIP-1 Receptor Agonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GIP-1 Receptor Agonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GIP-1 Receptor Agonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GIP-1 Receptor Agonist Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GIP-1 Receptor Agonist Production Market Share (2018-2023)
Table 42. Rest of World Based GIP-1 Receptor Agonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GIP-1 Receptor Agonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GIP-1 Receptor Agonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GIP-1 Receptor Agonist Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GIP-1 Receptor Agonist Production Market Share (2018-2023)
Table 47. World GIP-1 Receptor Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GIP-1 Receptor Agonist Production by Type (2018-2023) & (K Units)
Table 49. World GIP-1 Receptor Agonist Production by Type (2024-2029) & (K Units)
Table 50. World GIP-1 Receptor Agonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World GIP-1 Receptor Agonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World GIP-1 Receptor Agonist Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GIP-1 Receptor Agonist Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GIP-1 Receptor Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GIP-1 Receptor Agonist Production by Application (2018-2023) & (K Units)
Table 56. World GIP-1 Receptor Agonist Production by Application (2024-2029) & (K Units)
Table 57. World GIP-1 Receptor Agonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World GIP-1 Receptor Agonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World GIP-1 Receptor Agonist Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GIP-1 Receptor Agonist Average Price by Application (2024-2029) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK GIP-1 Receptor Agonist Product and Services
Table 64. GSK GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 68. Novo Nordisk Major Business
Table 69. Novo Nordisk GIP-1 Receptor Agonist Product and Services
Table 70. Novo Nordisk GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novo Nordisk Recent Developments/Updates
Table 72. Novo Nordisk Competitive Strengths & Weaknesses
Table 73. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly and Company Major Business
Table 75. Eli Lilly and Company GIP-1 Receptor Agonist Product and Services
Table 76. Eli Lilly and Company GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Eli Lilly and Company Recent Developments/Updates
Table 78. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 79. Baxter Pharmaceutical Solutions Basic Information, Manufacturing Base and Competitors
Table 80. Baxter Pharmaceutical Solutions Major Business
Table 81. Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Product and Services
Table 82. Baxter Pharmaceutical Solutions GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Baxter Pharmaceutical Solutions Recent Developments/Updates
Table 84. Baxter Pharmaceutical Solutions Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi GIP-1 Receptor Agonist Product and Services
Table 88. Sanofi GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 92. AstraZeneca Major Business
Table 93. AstraZeneca GIP-1 Receptor Agonist Product and Services
Table 94. AstraZeneca GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. AstraZeneca Recent Developments/Updates
Table 96. AstraZeneca Competitive Strengths & Weaknesses
Table 97. Shanghai Benemae Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai Benemae Pharmaceutical Corporation Major Business
Table 99. Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Product and Services
Table 100. Shanghai Benemae Pharmaceutical Corporation GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates
Table 102. Shanghai Benemae Pharmaceutical Corporation Competitive Strengths & Weaknesses
Table 103. Sinopep Allsino Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Sinopep Allsino Bio Pharmaceutical Major Business
Table 105. Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Product and Services
Table 106. Sinopep Allsino Bio Pharmaceutical GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sinopep Allsino Bio Pharmaceutical Recent Developments/Updates
Table 108. Sinopep Allsino Bio Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 110. Huadong Medicine Major Business
Table 111. Huadong Medicine GIP-1 Receptor Agonist Product and Services
Table 112. Huadong Medicine GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Huadong Medicine Recent Developments/Updates
Table 114. Huadong Medicine Competitive Strengths & Weaknesses
Table 115. HANSOH PHARMA Basic Information, Manufacturing Base and Competitors
Table 116. HANSOH PHARMA Major Business
Table 117. HANSOH PHARMA GIP-1 Receptor Agonist Product and Services
Table 118. HANSOH PHARMA GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. HANSOH PHARMA Recent Developments/Updates
Table 120. 3SBio Basic Information, Manufacturing Base and Competitors
Table 121. 3SBio Major Business
Table 122. 3SBio GIP-1 Receptor Agonist Product and Services
Table 123. 3SBio GIP-1 Receptor Agonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of GIP-1 Receptor Agonist Upstream (Raw Materials)
Table 125. GIP-1 Receptor Agonist Typical Customers
Table 126. GIP-1 Receptor Agonist Typical Distributors

List Of Figures

LIST OF FIGURES

Figure 1. GIP-1 Receptor Agonist Picture
Figure 2. World GIP-1 Receptor Agonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GIP-1 Receptor Agonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GIP-1 Receptor Agonist Production (2018-2029) & (K Units)
Figure 5. World GIP-1 Receptor Agonist Average Price (2018-2029) & (US$/Unit)
Figure 6. World GIP-1 Receptor Agonist Production Value Market Share by Region (2018-2029)
Figure 7. World GIP-1 Receptor Agonist Production Market Share by Region (2018-2029)
Figure 8. North America GIP-1 Receptor Agonist Production (2018-2029) & (K Units)
Figure 9. Europe GIP-1 Receptor Agonist Production (2018-2029) & (K Units)
Figure 10. China GIP-1 Receptor Agonist Production (2018-2029) & (K Units)
Figure 11. Japan GIP-1 Receptor Agonist Production (2018-2029) & (K Units)
Figure 12. GIP-1 Receptor Agonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 15. World GIP-1 Receptor Agonist Consumption Market Share by Region (2018-2029)
Figure 16. United States GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 17. China GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 18. Europe GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 19. Japan GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 20. South Korea GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 22. India GIP-1 Receptor Agonist Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GIP-1 Receptor Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GIP-1 Receptor Agonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GIP-1 Receptor Agonist Markets in 2022
Figure 26. United States VS China: GIP-1 Receptor Agonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GIP-1 Receptor Agonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GIP-1 Receptor Agonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GIP-1 Receptor Agonist Production Market Share 2022
Figure 30. China Based Manufacturers GIP-1 Receptor Agonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GIP-1 Receptor Agonist Production Market Share 2022
Figure 32. World GIP-1 Receptor Agonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GIP-1 Receptor Agonist Production Value Market Share by Type in 2022
Figure 34. Short-acting GLP-1 Receptor Agonist
Figure 35. Long-acting GLP-1 Receptor Agonist
Figure 36. World GIP-1 Receptor Agonist Production Market Share by Type (2018-2029)
Figure 37. World GIP-1 Receptor Agonist Production Value Market Share by Type (2018-2029)
Figure 38. World GIP-1 Receptor Agonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World GIP-1 Receptor Agonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World GIP-1 Receptor Agonist Production Value Market Share by Application in 2022
Figure 41. Type 2 Diabetics
Figure 42. Obese Patients
Figure 43. Others
Figure 44. World GIP-1 Receptor Agonist Production Market Share by Application (2018-2029)
Figure 45. World GIP-1 Receptor Agonist Production Value Market Share by Application (2018-2029)
Figure 46. World GIP-1 Receptor Agonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. GIP-1 Receptor Agonist Industry Chain
Figure 48. GIP-1 Receptor Agonist Procurement Model
Figure 49. GIP-1 Receptor Agonist Sales Model
Figure 50. GIP-1 Receptor Agonist Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source